Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Morgello

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Molecular Neurobiology|September 14, 2018
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV InfectionA R Kallianpur, H Gittleman, S Letendre, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
Journal of Neurovirology|September 18, 2014
Brain morphometric correlates of metabolic variables in HIV: the CHARTER studyS L Archibald, J A McCutchan, C Sanders, et al.
Journal of the International Neuropsychological Society : JINS|November 26, 2011
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioningK Blackstone, D J Moore, R K Heaton, et al.
Molecular Neurobiology|September 14, 2018
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV InfectionA R Kallianpur, H Gittleman, S Letendre, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Pageof 8